• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Cipla

Pharma

BMS, generics companies face new suit over Revlimid 'monopoly'

A class action antitrust lawsuit has been filed against BMS and a raft of generic drugmakers for allegedly maintaining a monopoly on Revlimid.
Kevin Dunleavy Nov 22, 2022 11:38am

Gilead can't escape antitrust suit centered on Cipla deal

Aug 23, 2022 1:44pm
image-icon

The top 10 generic drug makers by 2021 revenue

Jul 18, 2022 3:00am

Pfizer's MPP pact will provide COVID pill to 95 countries

Mar 18, 2022 10:05am

Tough decisions for Indian pharmas who do business with Russia

Mar 9, 2022 9:38am

Teva launches Revlimid generic, the first to do so in U.S.

Mar 7, 2022 11:11am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy